SCHEMBL8869428

SCHEMBL8869428

CCCCCC(=O)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCOC)nc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.49
P4HTM Q9NXG6 2/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
AKT1 P31749 4/20 0.44
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
PKM P14618 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8870497 0.94 P4HTM (0.49) PTPN1P4HTMCA1CA2GAA
SCHEMBL8869114 0.92 PTPN1 (0.51) PTPN1P4HTMCA1CA2GAA
SCHEMBL8868506 0.90 P4HTM (0.51) P4HTMCA1CA2GAAALDH1A1
SCHEMBL8870040 0.88 L3MBTL1 (0.48) P4HTMGAAALDH1A1MEN1KMT2A
SCHEMBL9138327 0.88 PTPN1 (0.52) PTPN1P4HTMCA1CA2SMN1; SMN2
SCHEMBL7862852 0.87 PTPN1 (0.47) PTPN1CA1CA2GAASMN1; SMN2
SCHEMBL8869547 0.86 CA2 (0.52) P4HTMCA2ALDH1A1
SCHEMBL8868734 0.86 L3MBTL1 (0.55) P4HTMALDH1A1MEN1KMT2APKM
SCHEMBL9138856 0.86 P4HTM (0.60) PTPN1P4HTMCA1CA2SMN1; SMN2
SCHEMBL8869116 0.86 P4HTM (0.53) P4HTMCA2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed